» Authors » Leif Lindstrom

Leif Lindstrom

Explore the profile of Leif Lindstrom including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 533
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nilsson B, Lindstrom L, Mohsen I, Holmlov K, Boden R
Schizophr Res . 2018 Apr; 199:403-406. PMID: 29602642
Tachycardia is associated with cardiovascular mortality. Tachycardia is also a known clozapine adverse effect. However, whether clozapine-associated tachycardia is persistent is not known. Thirty clozapine-treated patients with clinical tachycardia were...
2.
Nilsson B, Edstrom O, Lindstrom L, Wernegren P, Boden R
Int Clin Psychopharmacol . 2017 Feb; 32(4):219-224. PMID: 28225439
Tachycardia is a known adverse effect during clozapine treatment. However, prevalence reported differs widely between studies and hitherto there are no studies comparing clozapine-treated patients with a similar control group....
3.
Lindstrom L, Lindstrom E, Nilsson M, Hoistad M
J Affect Disord . 2017 Feb; 213:138-150. PMID: 28222360
Background: Second generations antipsychotics (SGA) are frequently used for maintenance treatment in bipolar disorder. We systematically reviewed the efficacy and long-term effects of treatment with SGA, regardless of treatment strategy...
4.
Ivarsson B, Malm U, Lindstrom L, Norlander T
Int J Psychiatry Clin Pract . 2014 Jun; 14(4):287-97. PMID: 24917441
Abstract Objective. The aim was to establish psychometric properties of the Global Quality of Life Scale (GQL) for people with severe mental illness. Methods. GQL is a stand-alone visual analogue...
5.
Boden R, Lindstrom E, Lindstrom L
Lakartidningen . 2011 Nov; 108(34):1570-1. PMID: 22066168
No abstract available.
6.
Boden R, Lindstrom L, Rautaharju P, Sundstrom J
Eur Psychiatry . 2011 Feb; 27(3):213-8. PMID: 21316200
Purpose: To explore measures in electrocardiograms (ECG) influenced by autonomic balance in early schizophrenia spectrum disorders and to examine their relation to subsequent first antipsychotic pharmacotherapy discontinuation and five-year remission...
7.
Olsson S, Samuelsson M, Saetre P, Lindstrom L, Jonsson E, Nordin C, et al.
J Psychiatry Neurosci . 2010 Apr; 35(3):195-9. PMID: 20420770
Background: Patients with schizophrenia show elevated brain levels of the neuroactive tryptophan metabolite kynurenic acid (KYNA). This astrocyte-derived mediator acts as a neuroprotectant and modulates sensory gating and cognitive function....
8.
Boden R, Haenni A, Lindstrom L, Sundstrom J
Schizophr Res . 2009 Oct; 115(2-3):141-5. PMID: 19846278
Obesity is a serious health issue for many patients with schizophrenia. There is a lack of predictors for and understanding of the development of obesity in the early phase of...
9.
Alenius M, Hammarlund-Udenaes M, Hartvig P, Sundquist S, Lindstrom L
Compr Psychiatry . 2009 Aug; 50(5):453-62. PMID: 19683616
Background: Various approaches have been made over the years to classify psychotic patients according to inadequate treatment response, using terms such as treatment resistant or treatment refractory. Existing classifications have...
10.
Boden R, Sundstrom J, Lindstrom E, Wieselgren I, Lindstrom L
Soc Psychiatry Psychiatr Epidemiol . 2009 Aug; 45(6):665-74. PMID: 19652896
Objective: Assertive community treatment programmes are increasingly common worldwide but without much knowledge of their long-term effect. We investigated whether the implementation of such a programme would improve symptomatic and...